எட் சார்லஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

APEIRON Biologics Announces Changes to Management and Supervisory Boards DGAP-News: APEIRON Biologics AG / Key word(s): Personnel 01.06.2021 / 10:00 APEIRON Biologics Announces Changes to Management and Supervisory Boards Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO) Prof. Josef Penninger moves from the Supervisory Board to the newly created Scientific Advisory Board, which he will build up and lead as Chairman APEIRON to propose Ulrich Granzer PhD as new member of the Supervisory Board at the upcoming Annual General Meeting Vienna, Austria, 1 June 2021: APEIRON Biologics AG, a privately held biotechnology company developing novel immunotherapies for cancer and respiratory diseases, today announced changes to the Company s Management and Supervisory Boards.

Andreas gerberMerck sharpe dohmeAndreas jungferEdward charlesRainer burianJulia hofmannJosef penningerUlrich granzerManfred reichlRomana gugenbergerFed charlesPharma knollPeter llewellyn daviesPharma ltdMc servicesBayer ag